Clinical Trial Update: Randomized Clinical Trial to Evaluate Immunogenicity and Safety in Mexicans Newborns [Phase 3]

View source ↗

Summary

A Phase 3 randomized clinical trial is evaluating immunogenicity and safety in newborns in Mexico for poliomyelitis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Snippet

Sponsor: Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. | Conditions: Poliomyelitis | Phase 3 | Status: UNKNOWN